Recombinant GFRA3 (Nadecnemab Biosimilar) antibody

Catalog No. ABIN7597839

This Human Monoclonal antibody specifically detects GFRA3 (Nadecnemab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant GFRA3 (Nadecnemab Biosimilar) antibody (ABIN7597839)

Target: GFRA3 (Nadecnemab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This GFRA3 (Nadecnemab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-GFRA3 (Nadecnemab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Nadecnemab Biosimilar Antibody

Specificity: GFR-alpha-3, GDNF receptor alpha-3, GDNF family receptor alpha-3, GDNFR-alpha-3, GFRA3

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for GFRA3 (Nadecnemab Biosimilar)

Target: GFRA3 (Nadecnemab Biosimilar)

Alternative Name: Nadecnemab Biosimilar

Target Type: Biosimilar

Background: GFR-alpha-3, GDNF receptor alpha-3, GDNF family receptor alpha-3, GDNFR-alpha-3, GFRA3

UniProt: O60609

CAS-No: 2377679-19-9